Insulin- and Obesity-related Variables in Early-stage Breast Cancer: Correlations and Time Course of Prognostic Associations
Overview
Authors
Affiliations
Purpose: To investigate patterns of prognostic associations over time of insulin- and obesity-related variables measured at diagnosis of early breast cancer (BC), focusing on whether the prognostic associations with distant recurrence and death changed over time.
Patients And Methods: Five hundred thirty-five nondiabetic women with T1-3, N0-1, M0 invasive BC diagnosed from 1989 to 1996 were included in the study. Insulin-related variables included fasting insulin, Homeostasis Model Assessment, C-peptide, and glucose. Obesity-related variables included weight, body mass index (BMI), waist and hip circumference, and leptin. Correlations were examined using the Pearson correlation coefficient and prognostic associations using the Cox model.
Results: There was evidence that associations of baseline insulin-related variables with distant recurrence and death were not constant over time; univariable adverse prognostic associations were significant only during the first 5 years (eg, insulin quartile 4 v 1: hazard ratio [HR], 2.32; 95% CI, 1.39 to 3.86; P < .001 for distant disease-free survival [DDFS]; and HR, 2.85; 95% CI, 1.48 to 5.50; P = .002 for overall survival [OS], with little attenuation of this pattern in multivariable analyses). In contrast, obesity-related variables (BMI, weight, leptin) exerted significant adverse univariable associations that were constant over time (eg, BMI quartile 4 v 2: HR, 1.40; 95% CI, 1.07 to 1.82 for DDFS; P = .014; and HR, 1.50; 95% CI, 1.16 to 1.93; P < .001 for OS); prognostic associations of leptin remained significant in multivariable analyses.
Conclusion: Baseline insulin- and obesity-related variables exert different patterns of prognostic associations over time in early BC.
Obesity-Associated Breast Cancer: Analysis of Risk Factors and Current Clinical Evaluation.
Engin A Adv Exp Med Biol. 2024; 1460:767-819.
PMID: 39287872 DOI: 10.1007/978-3-031-63657-8_26.
Javed S, Skolariki A, Zameer M, Lord S Br J Cancer. 2024; 131(11):1724-1736.
PMID: 39251829 PMC: 11589622. DOI: 10.1038/s41416-024-02833-1.
Xu K, Fu A, Li Z, Miao L, Lou Z, Jiang K Nat Commun. 2024; 15(1):1685.
PMID: 38402239 PMC: 10894219. DOI: 10.1038/s41467-024-45995-5.
Lin D, Sturgeon K, Gordon B, Brown J, Sears D, Sarwer D Nutrients. 2023; 15(15).
PMID: 37571390 PMC: 10421485. DOI: 10.3390/nu15153453.
Ruggieri L, Moretti A, Berardi R, Cona M, Dalu D, Villa C Int J Mol Sci. 2023; 24(5).
PMID: 36902406 PMC: 10002538. DOI: 10.3390/ijms24054974.